key: cord-0443437-9wt707xa authors: Patrone, Paul; Kearsley, Anthony title: Minimizing Uncertainty in Prevalence Estimates date: 2022-03-24 journal: nan DOI: nan sha: fe243376c73669eefc1c97cc9bb1df7fa2a7be35 doc_id: 443437 cord_uid: 9wt707xa Estimating prevalence, the fraction of a population with a certain medical condition, is fundamental to epidemiology. Traditional methods rely on classification of test samples taken at random from a population. Such approaches to estimating prevalence are biased and have uncontrolled uncertainty. Here, we construct a new, unbiased, minimum variance estimator for prevalence. Recent result show that prevalence can be estimated from counting arguments that compare the fraction of samples in an arbitrary subset of the measurement space to what is expected from conditional probability models of the diagnostic test. The variance of this estimator depends on both the choice of subset and the fraction of samples falling in it. We employ a bathtub principle to recast variance minimization as a one-dimensional optimization problem. Using symmetry properties, we show that the resulting objective function is well-behaved and can be numerically minimized. Estimating prevalence -the proportion of a population that has been infected by a disease -is a fundamental problem in epidemiology. Nonetheless, many core mathematical issues associated with this task have only been recently discovered and understood [1, 2] . For example, it has long been assumed that classification of samples as positive or negative is necessary to compute the prevalence. In Ref. [1] we demonstrated that this is false: unbiased estimators of prevalence can be constructed from conditional probability arguments having nothing to do with classification. The core idea of Ref. [1] was to recognize that the probability Q(r) of a diagnostic measurement outcome r in a space Ω ⊂ R N is given by the convex combination where q is the prevalence and P (r), N (r) are conditional probability density functions (PDFs) for positive and negative populations. Importantly, P (r) and N (r) can be constructed from training data and are thus known. Taking D to be an arbitrary subset of Ω, one can define q via where S D indicates the measure of D with respect to the arbitrary distribution S. 1 Given M samples drawn at random from a population and denoted r j , Eq. (2) implies that q can be estimated by where I is the indicator function. This estimate is unbiased and converges in mean square [1] . To solve the related and important problem of optimal prevalence estimation, we minimize the variance ofq, which is proportional to Equation (4) arises from the variance of the binomial random variableQ D but is unusual in that the denominator depends on a set that can be deformed arbitrarily. Thus, minimization is performed with respect to both the parameter Q D as well as the D. We reduce Eq. (4) to a one-dimensional (1D) problem by maximizing the denominator for fixed Q D . We construct this maximum in terms of a bathtub principle. Distinct sets D may yield the same Q D but different realizations of P D − N D . This motivates treating Q D as an independent variable, denoted byQ to avoid confusion. By rewriting Eq. (2) in terms ofQ, we find a constraint that defines the admissible D corresponding to eachQ. Clearly the collection of sets {D }Q whose elements maximize |P D −N D | (|·| denotes absolute value) for a fixedQ is an equivalence class. Since, each element in this class yields the same F (Q) = (P D − N D ) 2 as a function ofQ, minimizing Eq. (4) is equivalent to solving the 1D problem We next construct F (Q) by finding the equivalence class {D }Q. Equation (5) indicates that "loading" points r into D to increase |P D − N D | simultaneously increases N D . We therefore wish to construct D so as to increase |P D − N D | as much as possible and N D as little as possible. This motivates us to define the sets where and Eq. (8) defines ∆ ± in Eq. (7). The S ± are any sets satisfying both Eqs. (9) and the constraints given by Eq. (8). An optimality proof for these sets is closely related to the bathtub principle [3] . For completeness and to facilitate comparison to classification methods [1] , we present a proof adapted to the problem at hand. Lemma 1. Let 0 < q < 1, and assume every point r has zero measure with respect to P (r) and N (r). For fixedQ satisfying 0 N (r). Then on the open domain 0 0 for everyQ ∈ (0, 1). To demonstrate this, assume that there exists aQ ∞ for which P D+ − N D+ = 0. By assumption (ii) and the definition of D + , the remaining points in Ω/D + must have the property that P (r) < N (r). Integrating over this set shows that P Ω < N Ω , which violates the assumption that both are probability densities. Thus P D+ − N D+ cannot be zero in the interior of the domain, and σ 2 + (Q) is continuous on (0, 1). By definition, P D+ ≤Q and N D+ ≤Q, which implies that σ 2 + (Q) → ∞ in the limitQ → 0. The corresponding 4 result in the limitQ → 1 is proved in the same way by consideringQ → 0 for σ 2 − and then using Lemma 2. Existence of the minimum follows from divergence of σ 2 + (Q) at the boundaries and continuity in the interior (0, 1). Specifically, for any 0 < < 1/2, σ 2 + is continuous on D = [ , 1 − ]. By the extreme value theorem, there exists a valueQ ∈ D for which σ 2 + (Q) attains a minimum. Clearly there exists an 0 such that for all < 0 , σ 2 + (Q ) is constant, which defines the minimum. Remark: Assumption (ii) implies that there is a set of positive measure with respect to N for which N (r) > P (r). Remark: The assumption that there exists a set of positive measure for which P (r) > N (r) is an important feature of diagnostic tests; it implies the ability to distinguish populations. Failure to satisfy this condition is the hallmark of a useless diagnostic. The left plot of Fig. 1 shows training data and probability models for a SARS-CoV-2 immunoglobulin G (IgG) receptor binding domain (RBD) assay developed in Ref. [4] . The data was normalized according to the procedure in Ref. [1] . Following that, we added ε = 0.01 to all values and normalized all data by the largest positive value. While not necessary, adding ε facilitates model construction and otherwise has a negligible effect on the data, as it represents a perturbation of less than 1 % relative to the maximum scale of the data. We model N (r) with a Burr distribution [5] and approximate P (r) as a Beta distribution. Maximum likelihood estimation was used to determine model parameters. The Burr distribution was truncated to the domain 0 < r ≤ 1 and renormalized to have unit probability. The right plot of Fig. 1 The analysis presented herein does not refer to positive or negative populations. The functions P (r) and N (r) could have described two different populations having nothing to do with diagnostics. Our main result has implications for broader problems associated with estimating relative fractions of different populations. Our method suffers a need to empirically model training data, which may introduce uncertainty associated with the choices of distributions used. Addressing such tasks is necessary to fully understand all sources of uncertainty in prevalence estimates. The analysis herein is idealized insofar as it assumes that P (r) and N (r) are known exactly. In a related vein, construction of the optimal prevalence estimation domains requires a priori knowledge of q itself. Since this quantity is often what is being estimated, a practical algorithm for minimizing uncertainty in q would be to guess a trial domain based on any prior information, estimate q, and update the domain. While this approach will likely never converge in a mathematical sense, it should provide reasonable estimates motivated by the theory herein. Classification under uncertainty: data analysis for diagnostic antibody testing A statistical model of covid-19 testing in populations: effects of sampling bias and testing errors Crm Proceedings & Lecture Notes Quantification of antibody avidities and accurate detection of sars-cov-2 antibodies in serum and saliva on plasmonic substrates Cumulative Frequency Functions Acknowledgements: This work is a contribution of the National Institutes of Standards and Technology and is therefore not subject to copyright in the United States.Use of all data deriving from human subjects was approved by the NIST Research Protections Office.